What Is the First-Line Treatment for Childhood Absence Epilepsy?
Clinical Situation
This protocol addresses first-line pharmacological management of childhood absence epilepsy,
covering medication selection and titration for patients presenting with recurrent absence seizures.
Treatment Approach
Management begins with monotherapy. The full protocol specifies which agents carry Level A evidence,
along with the criteria for choosing among them — the complete selection guidance and titration
schedule are in the structured regimen.
Treatment Goal
Absence of recurrent seizures (seizure freedom).
Target: Seizure freedom
References
- Treatment should begin with monotherapy.
- The appropriate choice of medication varies depending on seizure type.
- Level A: ethosuximide (Zarontin), valproic acid
- Titrate over one to two weeks to maintenance dosage of 20 mg per kg daily
- Given once or twice daily, typically twice daily
- When patients have been seizure free for two to five years, discontinuation of antiepileptic drugs may be considered.
View source ↗